Hologic, Inc.  Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) its supply chain and improve manufacturing margins.
The combination of the companies should also facilitate further manufacturing efficiencies and accelerate research and development of new detector products.
AEG was a privately held group of companies headquartered in Warstein, Germany, with manufacturing operations in Germany, China and the United States.
The aggregate purchase price for AEG was approximately $31,300 (subject to adjustment) consisting of EUR $24,100 in cash and 110 shares of Hologic Common Stock valued at $5,300, and approximately $1,900 for acquisition related fees and expenses.
The Company determined the fair value of the shares issued in connection with the acquisition in accordance with EITF Issue No.99-12, Determination of the Measurement Date for the Market Price of Acquirer Securities Issued in a Purchase Business Combination.
These 110 shares were subject to contingent put options pursuant to which the holders had the option to resell the shares to the Company during a period of one year following the completion of the acquisition if the closing price of the Company’s stock falls and remains below a threshold price.
The put options were never exercised and expired on May 2, 2007.
The acquisition also provided for a one-year earn out of EUR 1,700 (approximately $2,000 USD) which was payable in cash if AEG calendar year 2006 earnings, as defined, exceeded a pre-determined amount.
AEG’s 2006 earnings did not exceed such pre-determined amounts and no payment was made.
The components and allocation of the purchase price, consists of the following approximate amounts:
## Table 0 ##
The Company implemented a plan to restructure certain of AEG’s historical activities.
The Company originally recorded a liability of approximately $2,100 in accordance with EITF Issue No.95-3, Recognition of Liabilities in Connection with a Purchase Business Combination, related to the termination of certain employees under this plan.
Upon completion of the plan in fiscal 2007 the Company reduced this liability by approximately $241 with a corresponding reduction in goodwill.
All amounts have been paid as of September 29, 2007.
As part of the AEG acquisition the Company acquired a minority interest in the equity securities of a private German company.
The Company estimated the fair value of these securities to be approximately $1,400 in its original purchase price allocation.
During the year ended September 29, 2007, the Company sold these securities for proceeds of approximately $2,150.
The difference of approximately $750 between the preliminary fair value estimate and proceeds upon sale has been recorded as a reduction of goodwill.
The final purchase price allocations were completed within one year of the acquisition and the adjustments did not have a material impact on the Company’s financial position or results of operations.
There have been no other material changes to the purchase price allocation as disclosed in the Company’s Form 10-K for the year ended September 30, 2006.
As part of the purchase price allocation, all intangible assets that were a part of the acquisition were identified and valued.
It was determined that only customer relationship, trade name, developed technology and know how and in-process research and development had separately identifiable values.
The fair value of these intangible assets was determined through the application of the income approach.
Customer relationship represents AEG’s high dependency on a small number of large accounts.
AEG markets its products through distributors as well as directly to its own customers.
Trade name represents AEG’s product names that the Company intends to continue to use.
Developed technology and know how represents currently marketable
On October 5, 2006, the Company announced a cash dividend of $0.12 per share on the Company’s common stock, payable on January 4, 2007 to stockholders of record as of December 7, 2006, which will be reflected in the consolidated financial statements in the first quarter of fiscal 2007.
Note 8.
Employee Stock Benefit Plans Employee Savings and Retirement Plan The Company has a 401(k) plan that allows eligible employees to contribute up to 50% of their eligible compensation, subject to annual limits.
The Company matches a portion of the employee contributions and may, at its discretion, make additional contributions based upon earnings.
The Company’s contribution expense for fiscal 2006, 2005 and 2004 was $33 million, $27 million and $21 million, respectively.
Equity Compensation Plans The Board of Directors may grant options to selected employees, directors and consultants to the Company to purchase shares of the Company’s common stock at a price not less than the fair market value of the stock at the date of grant.
The 2006 Long-Term Incentive Plan (the 2006 Plan) was adopted during the second quarter of fiscal 2006 and replaced the 2001 Stock Option Plan and the 2001 Non-Employee Director Stock Option Plan and their predecessor plans (the Prior Plans).
The 2006 Plan provides for the grant of incentive and nonstatutory stock options as well as stock appreciation rights, restricted stock, restricted stock units, performance units and shares and other stock-based awards and will be the source of shares issued under the Executive Retirement Matching Contribution Plan (ERMCP).
The share reserve under the 2006 Plan is equal to the shares available for future grant under the combined plans on the date the 2006 Plan was approved by the Company’s stockholders, plus an additional 65,000,000 shares for a total of approximately 280,192,000 shares reserved.
This share amount is automatically increased by the amount equal to the number of shares subject to any outstanding option under a Prior Plan that is terminated or cancelled (but not an option under a Prior Plan that expires) following the date that the 2006 Plan was approved by stockholders.
Shares that are subject to an award under the ERMCP and are returned to the Company because they fail to vest will again become available for grant under the 2006 Plan.
The Board of Directors of the Company may amend or terminate the 2006 Plan at any time.
Generally, options outstanding vest over periods not exceeding five years and are exercisable for up to ten years from the grant date.
During fiscal 2006, the Company assumed a total of approximately 3,530,000 outstanding stock options under the Flarion Technologies, Inc.  2000 Stock Option and Restricted Stock Purchase Plan, the Berkana Wireless Inc.  2002 Stock Plan and 2002 Executive Stock Plan and under the Qualphone Inc.  2004 Equity Incentive Plan (the Assumed Plans), as amended, as a result of the acquisitions (Note 11).
The Assumed Plans were suspended on the dates of acquisition, and no additional shares may be granted under those plans.
The Assumed Plans provided for the grant of both incentive stock options and non-qualified stock options.
Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to ten years from the grant date.
## Table 1 ##
nformation under FAS 123R for Fiscal 2006.
A summary of stock option transactions for all stock option plans follows:
(1)Represents activity related to options that were assumed as a result of acquisitions (Note 11).
Net stock options, after forfeitures and cancellations, granted during fiscal 2006, 2005 and 2004 represented 1.9%, 1.8% and 1.7% of outstanding shares as of the beginning of each fiscal year, respectively.
Total stock options granted during fiscal 2006, 2005 and 2004 represented 2.1%, 2.1% and 1.9%, respectively, of outstanding shares as of the end of each fiscal year.
Notes to Consolidated Financial Statements continued The Company’s determination of fair value of share-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables.
At September 24, 2006, total unrecognized estimated compensation cost related to non-vested stock options granted prior to that date was $1.2 billion, which is expected to be recognized over a weighted-average period of 1.7 years.
Total share-based compensation cost capitalized as part of inventory and fixed assets was $1 million during fiscal 2006.
The total intrinsic value of stock options exercised during fiscal 2006 was $1.1 billion.
The Company recorded cash received from the exercise of stock options of $608 million and related tax benefits of $421 million during fiscal 2006.
Upon option exercise, the Company issues new shares of stock.
Additional information about stock options outstanding at September 24, 2006 with exercise prices less than or above $37.86 per share, the closing price at September 24, 2006, follows (number of shares in thousands):
## Table 2 ##
Information under FAS 123 for Periods Prior to Fiscal 2006.
A summary of stock option transactions for all stock option plans follows (number of shares in thousands)

<table><tr><td>Net tangible assets acquired as of May 2, 2006</td><td>$24,800</td></tr><tr><td>In-process research and development</td><td>600</td></tr><tr><td>Developed technology and know how</td><td>1,900</td></tr><tr><td>Customer relationship</td><td>800</td></tr><tr><td>Trade name</td><td>400</td></tr><tr><td>Deferred income taxes</td><td>-3,000</td></tr><tr><td>Goodwill</td><td>5,800</td></tr><tr><td>Estimated Purchase Price</td><td>$31,300</td></tr></table>
<table><tr><td></td><td>Number of Shares (In thousands)</td><td> Weighted  Average  Exercise  Price</td><td> Average  Remaining  Contractual  Term  (Years)</td><td> Aggregate  Intrinsic  Value  (In billions)</td></tr><tr><td>Outstanding at September 25, 2005</td><td>202,794</td><td>$24.35</td><td></td><td></td></tr><tr><td>Options granted</td><td>34,977</td><td>45.69</td><td></td><td></td></tr><tr><td>Options assumed<sup>-1</sup></td><td>3,530</td><td>21.15</td><td></td><td></td></tr><tr><td>Options cancelled/forfeited/expired</td><td>-3,057</td><td>35.08</td><td></td><td></td></tr><tr><td>Options exercised</td><td>-36,389</td><td>16.71</td><td></td><td></td></tr><tr><td>Outstanding at September 24, 2006</td><td>201,855</td><td>$29.20</td><td>6.15</td><td>$2.2</td></tr><tr><td>Exercisable at September 24, 2006</td><td>121,872</td><td>$24.42</td><td>4.76</td><td>$1.8</td></tr></table>
<table><tr><td></td><td colspan="2"> Exercisable</td><td colspan="2"> Unexercisable</td><td colspan="2"> Total</td></tr><tr><td> Stock Options</td><td> Number  of Shares</td><td> Weighted  Average  Exercise  Price</td><td> Number  of Shares</td><td> Weighted  Average  Exercise  Price</td><td> Number  of Shares</td><td> Weighted  Average  Exercise  Price</td></tr><tr><td>Less than $37.86</td><td>98,804</td><td>$19.59</td><td>37,751</td><td>$26.57</td><td>136,555</td><td>$21.52</td></tr><tr><td>Above $37.86</td><td>23,068</td><td>45.10</td><td>42,232</td><td>45.36</td><td>65,300</td><td>45.27</td></tr><tr><td>Total outstanding</td><td>121,872</td><td>$24.42</td><td>79,983</td><td>$36.49</td><td>201,855</td><td>$29.20</td></tr></table>

Question: what is the fair value of hologic common stock?
Answer: 48.18182